Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$40.05 USD
-0.85 (-2.08%)
Updated Apr 17, 2024 03:59 PM ET
After-Market: $40.07 +0.02 (0.05%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | 0.78 |
EPS Last Quarter | 0.88 |
Last EPS Surprise | 1.15% |
ABR | 1.57 |
Earnings ESP
|
1.61% |
---|---|
Current Year | 3.71 |
Next Year | 4.36 |
EPS (TTM) | 3.30 |
P/E (F1) | 11.03 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 172.80M | 178.49M | 763.16M | 869.83M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 180.41M | 184.59M | 795.78M | 890.84M |
Low Estimate | 165.50M | 167.90M | 740.00M | 848.76M |
Year ago Sales | 140.02M | 145.71M | 644.40M | 763.16M |
Year over Year Growth Est. | 23.41% | 22.49% | 18.43% | 13.98% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.78 | 0.80 | 3.71 | 4.36 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | NA | NA | 3.65 | NA |
High Estimate | 0.84 | 0.86 | 3.98 | 4.44 |
Low Estimate | 0.72 | 0.70 | 3.44 | 4.23 |
Year ago EPS | 0.62 | 0.65 | 3.32 | 3.71 |
Year over Year Growth Est. | 25.81% | 23.08% | 11.75% | 17.51% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 0 |
Up Last 30 Days | 2 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.78 | 0.80 | 3.71 | 4.36 |
7 Days Ago | 0.74 | 0.80 | 3.70 | 4.36 |
30 Days Ago | 0.73 | 0.80 | 3.71 | 4.37 |
60 Days Ago | 0.70 | 0.83 | 3.88 | 4.46 |
90 Days Ago | 0.70 | 0.83 | 3.88 | 4.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.79 | 0.86 | 3.85 | 4.37 |
Zacks Consensus Estimate | 0.78 | 0.80 | 3.71 | 4.36 |
Earnings ESP | 1.61% | 7.50% | 3.70% | 0.29% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.88 | 1.15 | 0.65 | 0.62 | NA |
Estimate | 0.87 | 0.70 | 0.57 | 0.45 | NA |
Difference | 0.01 | 0.45 | 0.08 | 0.17 | 0.18 |
Surprise | 1.15% | 64.29% | 14.04% | 37.78% | 29.32% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more